Protara Therapeutics, Inc.
NASDAQTARA heads into its May 1 Q1 results with a notable gap between elevated short positioning and a Street that is uniformly — and aggressively — bullish. Short interest has climbed sharply in recent days, jumping nearly 10% in a single session on April 24 to reach 14.1% of the free float. That follows a period of partial covering through mid-April, when shorts had eased back from…
Snapshot as of 9 May 2026
TARA heads into its May 1 Q1 results with a notable gap between elevated short positioning and a Street that is uniformly — and aggressively — bullish. Short interest has climbed sharply in recent days, jumping nearly…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for TARA — free to start on ORTEX.
Sign up for free →Open TARA on ORTEX